BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 17, 2009
View Archived Issues
GeoVax presents update on clinical trials of its HIV/AIDS vaccine
Read More
Sanofi submits supplemental application to FDA for A(H1N1) pandemic vaccine
Read More
Clinical Data collaborates with CombinatoRx for novel B-cell cancer therapy
Read More
Terminal complement inhibitor eculizumab reduces clinical thrombosis in PNH patients
Read More
AZD-0530 fails to meet primary endpoint in phase II trial in extensive-stage SCLC
Read More
ADH-1 shows potent antitumor activity in vitro and in vivo in combination with erlotinib
Read More
ABT-869 combined with carboplatin/paclitaxel shown to be safe in NSCLC
Read More
Histamine H1 antagonist bilastine is safe in healthy human volunteers
Read More
CB1R antagonist AM-6545 improves plasma lipid profile and glucose tolerance in obese mice
Read More
Saphris approved by FDA for schizophrenia and bipolar I disorder
Read More
FDA approves Embeda for moderate to severe chronic pain
Read More
Abbott expands Xience V trial into crossover dual antiplatelet therapy trial
Read More
AGI and Axcan terminate AGI-010 agreement
Read More
FDA approves Pharming's IND for Prodarsan in Cockayne syndrome
Read More
NCI reports antiproliferative effect for cancer drug GAP-107B8
Read More
Pacgen acquires Xphase Pharmaceuticals
Read More
Patients enrolled in phase II Oncophage cancer vaccine trial in glioma
Read More
OncoGenex expands clinical development of OGX-427 in bladder cancer
Read More
Allergan claims sphingosine 1-phosphate receptor ligands as analgesics
Read More
Novel gamma-secretase modulators in early development at EnVivo Pharmaceuticals
Read More
First launch for Onglyza in U.S.
Read More
Endacea describes adenosine A1 antagonists as diagnostic agents
Read More
Merck Sharpe & Dohme and Merck & Co. report PARP inhibitors for cancer treatment
Read More
Panacos synthesizes new series of anti-HIV agents
Read More
Merck & Co. reports discovery of Cav2.2 calcium channel blocker with in vivo analgesic activity
Read More
